The Clorox Company (NYSE:CLX) Stock Position Decreased by M. Kulyk & Associates LLC

M. Kulyk & Associates LLC cut its position in shares of The Clorox Company (NYSE:CLXFree Report) by 5.6% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 24,719 shares of the company’s stock after selling 1,473 shares during the period. M. Kulyk & Associates LLC’s holdings in Clorox were worth $4,015,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently made changes to their positions in CLX. Brooklyn Investment Group raised its stake in shares of Clorox by 163.8% during the 4th quarter. Brooklyn Investment Group now owns 153 shares of the company’s stock worth $25,000 after purchasing an additional 95 shares in the last quarter. Prospera Private Wealth LLC purchased a new stake in shares of Clorox during the 3rd quarter worth about $27,000. Continuum Advisory LLC raised its stake in shares of Clorox by 300.0% during the 3rd quarter. Continuum Advisory LLC now owns 184 shares of the company’s stock worth $30,000 after purchasing an additional 138 shares in the last quarter. Asset Planning Inc purchased a new stake in shares of Clorox during the 4th quarter worth about $32,000. Finally, Halbert Hargrove Global Advisors LLC purchased a new stake in shares of Clorox during the 4th quarter worth about $36,000. 78.53% of the stock is owned by hedge funds and other institutional investors.

Clorox Price Performance

Shares of CLX stock opened at $151.11 on Friday. The stock has a 50 day moving average of $155.65 and a two-hundred day moving average of $160.40. The company has a current ratio of 0.94, a quick ratio of 0.60 and a debt-to-equity ratio of 20.52. The Clorox Company has a 12 month low of $127.60 and a 12 month high of $171.37. The company has a market capitalization of $18.61 billion, a P/E ratio of 41.29, a P/E/G ratio of 2.62 and a beta of 0.45.

Clorox (NYSE:CLXGet Free Report) last announced its quarterly earnings data on Monday, February 3rd. The company reported $1.55 EPS for the quarter, topping analysts’ consensus estimates of $1.39 by $0.16. Clorox had a return on equity of 316.87% and a net margin of 6.38%. During the same period in the prior year, the company posted $2.16 earnings per share. As a group, equities analysts expect that The Clorox Company will post 7.15 EPS for the current year.

Clorox Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, May 9th. Investors of record on Wednesday, April 23rd will be given a dividend of $1.22 per share. The ex-dividend date of this dividend is Wednesday, April 23rd. This represents a $4.88 annualized dividend and a dividend yield of 3.23%. Clorox’s dividend payout ratio (DPR) is presently 133.33%.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently weighed in on the company. JPMorgan Chase & Co. raised their price target on Clorox from $171.00 to $173.00 and gave the stock a “neutral” rating in a research note on Tuesday, February 4th. Evercore ISI increased their price objective on Clorox from $145.00 to $155.00 in a report on Tuesday, February 4th. Barclays increased their price objective on Clorox from $130.00 to $140.00 and gave the company an “underweight” rating in a report on Wednesday, February 5th. StockNews.com lowered Clorox from a “buy” rating to a “hold” rating in a report on Sunday, January 5th. Finally, DA Davidson lowered their target price on Clorox from $171.00 to $169.00 and set a “neutral” rating on the stock in a report on Wednesday, February 5th. Three analysts have rated the stock with a sell rating, eleven have assigned a hold rating and one has given a buy rating to the company’s stock. Based on data from MarketBeat, Clorox has a consensus rating of “Hold” and a consensus price target of $159.62.

Read Our Latest Stock Analysis on CLX

Clorox Profile

(Free Report)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

Recommended Stories

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.